MRI the classical MM1 and the atypical MV2 subtypes of sporadic CJD: An inter-observer agreement study

European Journal of Neurology

Volumn 15, Issue 8, 2008, Pages 762-771

  Krasnianski, A ^a   Kallenberg, K ^a   Collie, D A ^b   Meissner, B ^a   Schulz Schaeffer, W J ^a   Heinemann, U ^a   Varges, D ^a   Summers, D M ^b   Kretzschmar, H A ^c   Talbot, T ^d   Will, R G ^b   Zerr, I ^a,e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e Neurologische Klinik und Poliklinik   (Germany)

Author keywords

MM1 subtype; MRI; MV2 subtype; Sporadic creutzfeldt jakob disease; Thalamus

Indexed keywords

PRION PROTEIN;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CLINICAL FEATURE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THALAMUS; BRAIN; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

AGED; BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 54549111956     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02209.x     Document Type: Article

References (31)

1. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Annals of Neurology 1996; 39: 767-778.
2. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Annals of Neurology 1999; 46: 224-233.
3. Castellani RJ, Colucci M, Xie Z, et al. Sensitivity of 14-33 protein test varies in subtypes of sporadic Creutzfeldt - Jakob disease. Neurology 2004; 63: 436-442.
4. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in CJD: identification of uncommon variants. Annals of Neurology 2000; 48: 323-329.
5. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, et al. Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 2006; 129: 2288-2296.
6. Greitz D, Wirestam R, Franck A, Nordell B, Thomsen C, Stahlberg F. Pulsatile brain movement and associated hydrodynamics studied by magnetic resonance phase imaging. The Monro-Kellie doctrine revisited. Neuroradiology 1992; 34: 370-380.
7. Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt - Jakob disease. Archives of Neurology 1997; 54: 1411-1415.
8. Meissner B, Köhler K, Körtner K, et al. Sporadic Creutzfeldt-Jakob disease: Magnetic resonance imaging and clinical findings. Neurology 2004; 63: 450-456.
9. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-449.
10. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. American Journal of Roentgenology 2005; 184: 560-566.
11. Kallenberg K, Schulz-Schaeffer W, Jastrow U, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. American Journal of Neuroradiology 2006; 27: 1459-1462.
12. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. American Journal of Neuroradiology 2005; 26: 1551-1562.
13. Tschampa HJ, Kallenberg K, Urbach H, et al.MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128(Pt 9): 2026-2033.
14. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutz - feldt-Jakob disease. Neurology 2000; 55: 811-815.
15. WHO. Human transmissible spongiform encephalopathies. Weekly Epidemiological Record 1998; 47: 361-365.
16. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Cre - utzfeldt-Jakob disease. Archives of Neurology 1996; 53: 162-166.
17. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Annals of Neurology 1998; 43:32-40.
18. Kitamoto T, Shin RW, Doh-Ura K, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. The American Journal of Pathology 1992; 140: 1285-1294.
19. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Archives ofNeurology 1996; 53: 913-920.
20. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. The American Journal of Pathology 2000; 156: 51-56.
21. Windl O, Giese A, Schulz-Schaeffer W, et al. Molecular genetics of human prion diseases in Germany. Human Genetics 1999; 105: 244-252.
22. Colchester ACF, Hojjat SA, Zerr I, Collie DA. MR intensity analysis to discriminate variant, sporadic CJD, and non-CJD dementia patients. Journal of Neurology, Neurosurgery, and Psychiatry 2004; 75: 41.
23. Linguraru MG, Ayache N, Bardinet E, et al. Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain - definition and evaluation of new MRI-based ratios. IEEE Transactions on Medical Imaging 2006; 25: 1052-1067.
24. Meissner B, Westner I, Kallenberg K, et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-1550.
25. Kovacs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Human Genetics 2005; 118: 166-174.
26. Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clinical Radiology 2001; 56: 726-739.
27. Petzold GC, Westner I, Bohner G, Einhäupl KN, Kretzschmar H, Valdueza JN. False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology 2004; 62: 1235-1236.
28. Haik S, Dormont D, Faucheux BA, Marsault C, Hauw JJ. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Annals ofNeurology 2002; 51: 797-799.
29. Rossetti AO, Glatzel M, Aguzzi A, Janzer R, Bogous - slavsky J. Clinical and radiological mimicry of vCJD in a valine homozygous PrP(Sc) type 1 sCJD patient. Journal of Neurology 2003; 250: 491-493.
30. Fukushima R, Shiga Y, Nakamura M, Fujimori J, Kit - amato T, Yoshida Y. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrP type 2 in Japan. Journal ofNeurol - ogy, Neurosurgery, and Psychiatry 2004; 75: 485-487.
31. Martindale J, Geschwind M, De Armond S, et al. Sporadic Creutzfeldt-Jakob disease mimicking variant Cre - utzfeldt-Jakob disease. Archives ofNeurology 2003; 60: 767-770.